Funding

• National Funding
  • CD Laboratory for Chemical Epigenetics and Antiinfectives
  • FFG Bridge "ImmunoDegraders"
  • FWF DK W 1212-B21 "IAI"
  • FWF SFB F 4711-B20 "Myeloproliferative Neoplasms"
  • FWF SFB F 6102-B21 "Chromatin Landscapes"
  • FWF SFB F 5402-B21 "Microparticles as modulators of inflammation and thrombosis"
  • FWF SFB F 4701-B20 "Myeloproliferative Neoplasms"
  • FWF SFB F 7002-B21 "HDACs as regulators of T cell-mediated immunity in health and disease"
  • FWF SFB F 7909-B "Chemical probing and functional characterization of the E3 substrate receptor DCAF15"
  • FWF Stand-Alone P 29763-B27
  • FWF Stand-Alone P 30047-B30
  • FWF Stand-Alone P 30271 - B28
  • FWF Stand-Alone P 32125-B
  • FWF Stand-Alone P 31690-B28
  • FWF Stand-Alone P 30041-B26
  • FWF Stand-Alone P 31113-B30
  • FWF TRANSCAN I 2798-B28 "CEVIR"
  • OeAW New Frontier Group 2013
  • OeAW NFRI 2015
  • WWTF Vienna Research Group Leader
  • WWTF LS16-034 "PHARMACOSCOPY"
  • WWTF LS16-060 "PrecisePID"
  • WWTF LS17-059 "3C - Cellular Color Chart"
  • WWTF LS18 - 058 "Systems medicine analysis of sarcoidosis by targeting mTOR in a co-clinical trial in patients and mice"
  • WWTF LS18 - 049 "Characterizing and targeting the Ewing sarcoma microenvironment to overcome resistance to therapy"
  • WWTF LS18 - 111 "Ultra-high-risk pediatric cancer - combinatorial drivers and therapeutic targets for precision medicine"
  • WWTF NXT19-008 "DataDiVR"
• International Funding
• Fellowships